Doç. Dr. Sevda Sağlampınar Karyağar
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Thyroid Neoplasms 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Colorectal Neoplasms 2 publications
- Skin Neoplasms 2 publications
- Adenocarcinoma 2 publications
- Carcinoma, Non-Small-Cell Lung 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyNuclear Medicinesaglik.gov.trFrom source
- Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
- Area of workThyroid NeoplasmsExtracted from 3 publications · Model version —From source
- Publications33 publicationsOpenAlex, Europe PMC, ORCIDFrom source
- ORCID0000-0002-6356-8280ORCIDFrom source
- Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563433/doktorlarimiz.html#sevda-saglampinar-karyagarsaglik.gov.tr
Scientific work
Publications on Thyroid Neoplasms
-
Malignant Phosphaturic Mesenchymal Tumor With Lung Metastasis
Cureus, 2026
DOI 10.7759/cureus.102504 PMID 41769508 Open-access full textSource: OpenAlex
-
Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer
Molecular imaging and radionuclide therapy, 2023
DOI 10.4274/mirt.galenos.2022.05826 PMID 37337764 4 citations (Europe PMC) Open-access full textSource: Europe PMC
-
Contribution of Lower Extremity 68Ga PSMA PET/CT Imaging to Diagnosis and Treatment in Prostate Cancer
European Archives of Medical Research, 2022
DOI 10.4274/eamr.galenos.2021.50251 Open-access full textSource: OpenAlex
-
The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
Journal of Gastrointestinal Cancer, 2021
DOI 10.1007/s12029-021-00608-y PMID 33651265 11 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?
Nuclear Medicine Communications, 2021
DOI 10.1097/mnm.0000000000001431 PMID 33958536 7 citations (Europe PMC) Source: ORCID
-
Thyroid Cancer Prevalence and Risk in Incidental Thyroid Lesions Detected with 18F-FDG PET/CT
European Archives of Medical Research, 2021
DOI 10.4274/eamr.galenos.2020.94803 Open-access full textSource: OpenAlex
-
The relationship between pre-treatment 18F-FDG PET/CT metabolic data and treatment response in patients with cervix uteri cancer.
PubMed, 2021
DOI 10.1967/s002449912302 PMID 33866335 2 citations (OpenAlex) Source: OpenAlex
-
Bone Metastases on 18F-FDG PET/CT Imaging in Patients with Colorectal Cancer. Does Bone Scintigraphy Still Have a Role?
Eurasian Journal of Medical Investigation, 2021
DOI 10.14744/ejmi.2021.86631 Source: OpenAlex
-
The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer
Journal of Oncology Pharmacy Practice, 2020
DOI 10.1177/1078155219898504 PMID 31955700 3 citations (Europe PMC) Source: OpenAlex
-
The correlation between tumor markers and Ga-68 DOTA-TATE PET/CT findings in patients with advanced medullary thyroid cancer
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2020
DOI 10.1016/j.remnie.2020.04.005 PMID 33451923 1 citation (Europe PMC) Open-access full textSource: OpenAlex